Found 11 matching trials
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
PHASE2This is a prospective, multi-cohort, single-arm Phase II clinical trial eva...
Location
2nd Affiliated Hospital, School of Medicine
ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy
PHASE2Befotertinib is a third-generation EGFR-TKI independently developed in Chin...
Location
The Fourth Hospital of Hebei Medical University
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
PHASE2This research study aims to explore the combination of two targeted drugs a...
Location
Sun Yat-sen University Cancer Center
Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients
PHASE2This is a multicenter, phase II exploratory clinical trial in untreated pat...
Location
Guangdong Provincial Hospital of Chinese Medicine
Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation
PHASE1To evaluate the safety and tolerance of MCLA-129 combined with Befotertinib...
Location
The first affiliated hospital of bengbu medical college
Therapy for Advanced NSCLC With EGFR 19delins Mutation
EARLY_PHASE1In a retrospective analysis of 3,054 advanced NSCLC patients, 41 with EGFR ...
Location
Multiple Locations
Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations
PHASE3This multicenter, randomized, controlled, double-blind, double-simulated, P...
Location
Peking University International Hospital
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
PHASE2Non-small cell lung cancer (NSCLC) accounts for over 85% of lung cancers. A...
Location
Sun Yat-sen University Cancer Center
Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients
PHASE4To evaluate 3-year disease-free survival after complete resection in patien...
Location
Fudan University Cancer Center
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
PHASE2This research study is studying a combination of two drugs as a possible tr...
Status
Active Not Recruiting